ライフサイエンスコーパス: polyangiitis

1 orbital inflammation, or granulomatosis with polyangiitis.

2 f the PR3 autoantigen in granulomatosis with polyangiitis.

3 toplasmic antibodies) in granulomatosis with polyangiitis.

4 ith diagnosed Wegener disease or microscopic polyangiitis.

5 ce injury in MPO-ANCA-associated microscopic polyangiitis.

6 reatment of eosinophilic granulomatosis with polyangiitis.

7 as Wegener's granulomatosis) and microscopic polyangiitis.

8 ther Wegener's granulomatosis or microscopic polyangiitis.

9 condition a separate entity from microscopic polyangiitis.

10 is as Wegener granulomatosis and microscopic polyangiitis.

11 egener's granulomatosis [WG], 12 microscopic polyangiitis, 16 Churg-Strauss syndrome [CSS]), and anti

12 rolled patients (87 with granulomatosis with polyangiitis, 23 with microscopic polyangiitis, and 5 wi

13 trophil cytoplasm Abs in granulomatosis with polyangiitis, a form of systemic vasculitis.

14 c autoantibody (ANCA)-associated microscopic polyangiitis and glomerulonephritis (excluding Wegener's

15 tic distinctions between granulomatosis with polyangiitis and microscopic polyangiitis that are assoc

16 vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetical

17 resistance in 107 patients with microscopic polyangiitis and necrotizing and crescentic glomerulonep

18 small vessel vasculitis, such as microscopic polyangiitis and Wegener granulomatosis.

19 d AAV (Wegener granulomatosis or microscopic polyangiitis) and were aged 18 to 75 years at diagnosis.

20 tosis with polyangiitis, 23 with microscopic polyangiitis, and 5 with renal-limited ANCA-associated v

21 lomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome.

22 orders such as granulomatous or eosinophilic polyangiitis, and sarcoidoisis.

23 with Wegener granulomatosis and microscopic polyangiitis are derived by extrapolating from data abou

24 Severe microscopic polyangiitis can result in acute respiratory failure and

25 esponses in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome); and matrix metall

26 e of RTX in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

27 Eosinophilic granulomatosis with polyangiitis (Churg-Strauss, EGPA) is a systemic small-v

28 (MPA), and eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA), also collectively re

29 Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis with a

30 (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss), are a group

31 phils from patients with granulomatosis with polyangiitis expressing high membrane PR3 levels showed

32 ing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis

33 vation of neutrophils in granulomatosis with polyangiitis (formerly Wegener disease).

34 a 15-year-old girl with granulomatosis with polyangiitis, formerly known as Wegener's granulomatosis

35 tion with categories for granulomatosis with polyangiitis (GPA) (Wegener's), microscopic polyangiitis

36 mal gland involvement in granulomatosis with polyangiitis (GPA) commonly accompanies orbital disease,

37 Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis

38 Granulomatosis with polyangiitis (GPA), previously Wegener's granulomatosis,

39 mune vasculitis, such as granulomatosis with polyangiitis (GPA).

40 omatous lesions found in granulomatosis with polyangiitis (GPA, formerly Wegener's) or the developmen

41 associated vasculitides, granulomatosis with polyangiitis (GPA, formerly Wegener's), microscopic poly

42 systemic vasculitis and granulomatosis with polyangiitis (GPA, Wegener's granulomatosis).

43 A key feature of granulomatosis with polyangiitis (GPA; or Wegener's granulomatosis) is the g

44 al features of kidney disease in microscopic polyangiitis have been associated with clinical presenta

45 monstrates greater similarity to microscopic polyangiitis in relapse rate than previously reported.

46 Microscopic polyangiitis is a subgroup of primary systemic vasculiti

47 Microscopic polyangiitis is an autoimmune small-vessel vasculitis th

48 Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis.

49 Microscopic polyangiitis is defined within the context of primary sy

50 nagement of renal involvement in microscopic polyangiitis is discussed, with emphasis on prognosis an

51 PR3), the autoantigen in granulomatosis with polyangiitis, is expressed at the plasma membrane of res

52 sis, Churg-Strauss syndrome, and microscopic polyangiitis, is impeded by the small number of pediatri

53 ipants with eosinophilic granulomatosis with polyangiitis, mepolizumab resulted in significantly more

54 cludes Wegener's granulomatosis, microscopic polyangiitis (microscopic polyarteritis), the Churg-Stra

55 y diagnosed or relapsing granulomatosis with polyangiitis, microscopic polyangiitis, or renal-limited

56 tinction between classic PAN and microscopic polyangiitis (MPA) has not always been made.

57 egener's granulomatosis (WG) and microscopic polyangiitis (MPA) have been reported to be pathological

58 Microscopic polyangiitis (MPA) may present with a syndrome that rese

59 iitis (GPA, formerly Wegener's), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with

60 h polyangiitis (Wegener's; GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with

61 polyangiitis (GPA) (Wegener's), microscopic polyangiitis (MPA), and kidney-limited disease; 2) the E

62 hy include polyarteritis nodosa, microscopic polyangiitis (MPA), rheumatoid vasculitis, Churg-Strauss

63 egener's granulomatosis (WG) and microscopic polyangiitis (MPA).

64 ve patients (64 with WG, 14 with microscopic polyangiitis [MPA], and 526 others) and 45 healthy volun

65 creased in patients with granulomatosis with polyangiitis, MVs generated from neutrophils expressing

66 ived a KTX for ESRD secondary to microscopic polyangiitis (n=43) or Wegener's granulomatosis (n=42).

67 oncluded that most patients with microscopic polyangiitis or necrotizing and crescentic glomeruloneph

68 matosis with polyangiitis versus microscopic polyangiitis), or new diagnosis (versus relapsing diseas

69 ranulomatosis with polyangiitis, microscopic polyangiitis, or renal-limited ANCA-associated vasculiti

70 rythematosus (P = 2.7 x 10(-8)), microscopic polyangiitis (P = 2.9 x 10(-4)) and Wegener's granulomat

71 il cytoplasmic antibody-positive microscopic polyangiitis, resulting in pulmonary hemorrhage and acut

72 ommon at high latitudes, whereas microscopic polyangiitis shows the reverse pattern.

73 ulomatosis with polyangiitis and microscopic polyangiitis that are associated with ANCA specificity,

74 ntrolling for age, ANCA pattern, microscopic polyangiitis versus glomerulonephritis alone, and pulmon

75 NCA type, AAV diagnosis (granulomatosis with polyangiitis versus microscopic polyangiitis), or new di

76 s with chronic relapsing granulomatosis with polyangiitis (Wegener's) (GPA).

77 eported in patients with granulomatosis with polyangiitis (Wegener's) (GPA).

78 cluded 180 patients with granulomatosis with polyangiitis (Wegener's) (GPA).

79 Granulomatosis with polyangiitis (Wegener's) is a rare autoimmune neutrophil

80 esis and presentation of granulomatosis with polyangiitis (Wegener's).

81 b (RTX) in patients with granulomatosis with polyangiitis (Wegener's; GPA), microscopic polyangiitis

82 ulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct.

83 , including 69 with evidence for microscopic polyangiitis, were evaluated for this study.

84 itivity and eosinophilic granulomatosis with polyangiitis, which accounted for 34.1% and 12.8% of cas

85 refractory eosinophilic granulomatosis with polyangiitis who had received treatment for at least 4 w